Table 4.
Feasibility and gap analysis under scenario 1.
| Overall approach | Revenue minus the total cost of defined package, analyzed for different scenarios of revenue and cost. Analysis was done for maternal and child target beneficiaries at the state level per year. | |
|---|---|---|
| Cost | Revenue | |
| Scenario 1a | Drugs and Consumables only | 0.5(1%CRF) = NHIS only |
| Scenario 1b | Drugs and Consumables only | 0.7(1%CRF) = 0.5: NHIS for basic package and 0.2: NPHCDA for drugs and consumables only |
| Scenario 1c | Drugs and Consumables only | 0.95(1%CRF) = 0.5: NHIS for basic package and 0.45: NPHCDA |
| Scenario 1d | Drugs and Consumables only | 0.5(1%CRF) + 0.25[0.5(1%CRF)]* *State's counterpart fund |
| Scenario 1e | Drugs and Consumables only | 0.7(1%CRF) + 0.25[0.7(1%CRF)]* *State's counterpart fund |
| Scenario 1f | Drugs and Consumables only | 0.95(1%CRF) + 0.25[0.95(1%CRF)]* *State's counterpart fund |